Grace Therapeutics, Inc. (GRCE) dividend history

GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31

Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30

$1.81+0.00 (0.00%)

Close on Nov 13, 2026Market cap $38.08MP/E –Yield –

Dividends

No dividend per share appears in Grace Therapeutics's annual filings since fiscal 2016.

See a number that looks wrong?